By Marilynn Marchione A new study reports one of the biggest potential advances against heart failure in more than a decade -- a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent. Doctors say theaNovartis drug -- which doesn't have a name yet -- seems like one of those rare, breakthrough therapies that could quickly change care for more than half of the 6 million Americans and 24 million people worldwide with heart failure. "This is a new day" for patients, said Dr.
Similar Stories to Study: New Novartis Heart Failure Drug Shows Big Promise on Bing News
twocents@thestreet.com (The Associated Press), The Street
Sat, 08/30/2014 - 4:07pm
Topics: marilynn marchione a doctors americans dr clyde yancy northwestern university chicago american heart association basel switzerland dr milton packer ut southwestern medical center dallas results cardiology barcelona new england journal medicine novartisawill lcz696 united states heart ace vasotec novartisadrug dr joseph g rogers duke university dr mariell jessup pennsylvania nvs drugs heart europe click study big people older percent decade hospitalized blood patients death chances year effectively pump breakthrough experimental chief enalapril role million reason
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more